Navigation Links
BioElectronics Launches '1 Day Breast Augmentation Recovery Kit'
Date:3/13/2008

Meets the Growing Demand for Quicker Surgical Recoveries

FREDERICK, Md., March 13 /PRNewswire-FirstCall/ -- BioElectronics Corporation (BIEL) announces the product launch of its Breast Recovery Kit, for the relief of edema and post operative discomfort.

Developed by Dr. Barry Eppley, MD, DMD, the 1 Day Breast Recovery Kit allows breast surgery patients to return to their active lives the day after surgery. Using the patented technology, ActiPatch relieves edema and discomfort without drugs, ice, or topical ointments. Priced below $50.00 it is an excellent alternative to pain pumps, which pose a risk of infection, or oral analgesics and anti-inflammatory medications -- which many patients prefer not to take or cannot tolerate.

Dr. Barry L. Eppley is an extensively trained and unique plastic surgeon. Dr. Eppley received a Doctor of Medicine degree from Washington University in St. Louis as well as a Doctor of Dental Medicine degree from the University of Pennsylvania in Philadelphia. Dr. Eppley completed training in Oral and Maxillofacial Surgery at Barnes Hospital and St. John's Mercy Medical Center Hospital while in St. Louis. He furthered his training in General Surgery, Craniofacial and Cleft Surgery as well as full training in Plastic and Reconstructive Surgery at Indiana University. As a result of this education, Dr. Eppley is both a licensed physician and dentist and board certified in the specialties of Plastic and Reconstructive Surgery as well as Oral and Maxillofacial Surgery. This background brings a diverse experience and perspective to the requirements needed for facial plastic, craniofacial and maxillofacial, and cosmetic body contouring surgeries. For more visit: http://www.dreppley.com.

"We are thrilled and quite fortunate to have such a talented surgeon and educator as Dr. Eppley assisting in our product development. We look forward to his insight and help in our mission to change the way people heal," said BioElectronics' President Andrew Whelan.

ActiPatch(TM) is a drug-free, anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

ActiPatch has regulatory clearance by the FDA for the treatment of edema following blepharoplasty.

For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioElectronics Corporation Announces Singapore and Malaysia Sales
2. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
3. BioElectronics Announces Canadian Retail Product Launch
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):